Roland Kolbeck

机构：AstraZeneca (Australia), AstraZeneca (Canada)

发表论文 131 篇 · 总被引 13338 次 · h-index 58

代表论文

• IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE (2018 · Nature Communications · 被引 600)
• Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond (2018 · Advanced Drug Delivery Reviews · 被引 347)
• Benralizumab for PDGFRA -Negative Hypereosinophilic Syndrome (2019 · New England Journal of Medicine · 被引 219)
• Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus (2019 · Annals of the Rheumatic Diseases · 被引 170)
• Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus (2018 · Lupus Science & Medicine · 被引 153)
• Role of IgE in autoimmunity (2016 · Journal of Allergy and Clinical Immunology · 被引 136)